GlassScriptPhysician profile
Zohaib Akhtar
NPI 1760896633
$6,387.70
in general payments reported to CMS, 2019-2025
18 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $71.83 · 2021: $534 · 2022: $453 · 2023: $951 · 2024: $4,270 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,600 · Travel and Lodging: $1,654 · Food and Beverage: $1,075.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,599.99 |
| Travel and Lodging | $1,653.67 |
| Food and Beverage | $1,074.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,246.67 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $430.28 | 2020-2023 | Breztri, Symbicort |
| Glaxosmithkline, LLC. | $403.47 | 2020-2025 | Trelegy Ellipta, Nucala |
| Atricure, INC. | $298.53 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $247.46 | 2021-2023 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Electromed, INC. | $177.20 | 2022-2024 | Smartvest |
| Mallinckrodt Hospital Products INC. | $168.22 | 2023 | Acthar |
| Genzyme Corporation | $103.00 | 2022-2023 | |
| Philips North America LLC | $69.68 | 2021-2023 | |
| Medical Device Business Services, INC. | $47.39 | 2023 | |
| Amgen INC. | $34.89 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $28.64 | 2023 | Dupixent |
| Baxter Healthcare | $26.54 | 2023 | Hillrom - Life 2000 Ventilation System |
| Takeda Pharmaceuticals U.S.A., INC. | $26.08 | 2023 | Glassia |
| Actelion Pharmaceuticals US, INC. | $25.58 | 2023 | Opsumit, Uptravi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $18.89 | 2023 | Monarch Platform |
| Insmed, INC. | $18.53 | 2022 | |
| Becton, Dickinson and Company | $16.65 | 2025 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zohaib Akhtar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.